OpenLegislation

Regulation 191 Amendment of regulation 233 (exemption for supply etc under a PGD by a person conducting a retail pharmacy business)I1F1

United Kingdom

For regulation 233(7) substitute—

“(7)

Condition F is that when the prescription only medicine is supplied or (as the case may be) administered—

(a)

in Northern Ireland, a UKMA(NI), UKMA(UK), EU marketing authorisation, Article 126a authorisation, certificate of registration, THR(NI) or THR(UK), or

(b)

in Great Britain, a UKMA(GB), UKMA(UK), certificate of registration, THR(GB) or THR(UK),

is in force in relation to it.”.

Annotations

Textual amendments

F1

Reg. 191 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 145

Commencement

I1

Reg. 191 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1